Influenza Vaccine in Children With Asthma

Asthma in Children Clinical Trial

— VAGA  

Official title:

Evaluation of the Immunization Coverage Against Influenza in Children With Asthma Followed at the Hospital of Nancy

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04086628
• Other study ID #: 2019-A01944-53
• Status: Recruiting
• Start date: November 4, 2019
• Est. completion date: April 2020

Study information

• Verified date: December 2019
• Source: Central Hospital, Nancy, France
• Contact: Aurore Blondé, Dr
• Phone: 0383154603
• Email: a.blonde[@]chru-nancy.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The occurence of influenza can be a factor of imbalance of asthma. Asthma patients are recommended for annual influenza vaccination . However there is insufficient vaccination coverage of asthmatic patients despite this recommendation. The aim of this study is to evaluate the rate of influenza vaccination coverage of children with asthma aged from 6 month to 17 years of age followed in pediatric pneumology consultation at the university hospital of Nancy.

Description:

Using a questionnaire, the investigator will estimate the percentage of the asthmatic patients vaccinated against influenza. He will then compare the 2 groups of vaccinated and unvaccinated patients : comparison of patients characteristics, comparison of asthma characteristics (severity, asthma control...). He will also analyze the causes of vaccination or non-vaccination.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: April 2020
• Est. primary completion date: April 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Months to 17 Years

Eligibility

Inclusion Criteria:

• asthmatic patients followed in pediatric pneumology consultation at university hospital of Nancy aged from 6 months to 17 years

Exclusion Criteria:

• asthmatic children who have been followed for less than 1 year

Related Conditions & MeSH terms

• Asthma
• Asthma in Children
• Immunization Coverage
• Influenza Vaccine
• Influenza, Human

Locations

Country	Name	City	State
France	CHRU Nancy	Vandoeuvre les Nancy

Sponsors (1)

Lead Sponsor	Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of asthmatic patients vaccinated against influenza	Percentage of patients vaccinated against influenza will be evaluate among children with asthma followed in pediatric pneumology consultation.	through study completion, an average of 6 months
Secondary	Socio-demographic characteristics of patients	Socio-demographic characteristics will be recorded from the questionnaire and compare between the 2 groups : vaccinated and unvaccinated patients.	through study completion, an average of 6 months
Secondary	Age of patients (years)	Age of patients will be recorded from the questionnaire and compared between the 2 groups : vaccinated and unvaccinated patients.	through study completion, an average of 6 months
Secondary	Asthma severity (mild, moderate, severe asthma)	Asthma severity (mild, moderate, severe asthma) is assessed from the level of treatment required to control symptoms according to Global Initiative for Asthma (GINA) 2018 recommendations. The investigator will compare asthma severity between the 2 groups : vaccinated and unvaccinated patients.	through study completion, an average of 6 months
Secondary	Asthma symptom control (well controled, partly controlled, uncontrolled)	Level of asthma symptoms control (well controled, partly controlled, uncontrolled) is assessed from symptoms control tool, according to GINA 2018 recommendations. The investigator will compare asthma symptom control between the 2 groups : vaccinated and unvaccinated patients.	through study completion, an average of 6 months